Evidence Hub

Inflammatory risk and cardiovascular events in patients without obstructive coronary artery disease (The Oxford Risk Factors And Non-invasive imaging study): A multicentre, longitudinal cohort study

Kenneth Chan, Elizabeth Wahome, A. Tsiachristas, A. Antonopoulos, P. Patel, M. Lyasheva, L. Kingham, H. West et al.

The Lancet, 2024

40,091 participants · 188 citations

Abstract

SUMMARY Background: Coronary computed tomography angiography (CCTA) is the first line investigation for chest pain, and it is used to guide revascularisation. However, the widespread adoption of CCTA has revealed a large group of individuals without obstructive coronary artery disease (CAD), with unclear prognosis and management. Measurement of coronary inflammation from CCTA using perivascular fat attenuation index (FAI) Score could enable cardiovascular risk prediction and guide the management of individuals without obstructive CAD. Methods: Consecutive patients undergoing clinically indicated CCTA in 8 UK hospitals (n=40,091) were followed for Major Adverse Cardiac Events (MACE; myocardial infarction, new onset heart failure, or cardiac death) for a median(IQR) of 2·7(1·4–5·3)years. The prognostic value of FAI Score in the presence and absence of obstructive CAD was evaluated in 3,393 consecutive patients from the 2 hospitals with the longest follow up [7·7(6·4–9·1)years]. An artificial intelligence-enhanced cardiac risk prediction algorithm (AI-Risk), that integrates FAI Score, coronary plaque metrics and clinical risk factors, was then evaluated in this population. Findings: Patients without obstructive CAD (n=32,533, 81·1%) accounted for 66·3% (n=2,857) of MACE and 63·7% (n=1,118) of cardiac deaths during follow up. Increased FAI Score in all the three coronary arteries had an additive impact on the risk for cardiac mortality (HR 29∙8, 95% CI 13∙9–63∙0, P<0.001) or…

How strong is the evidence?

Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 40,091 participants or records.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free